Vanda Pharmaceuticals Achieves Breakthrough in GLP-1 Induced Nausea Treatment

Vanda Pharmaceuticals shares are trading higher after the company reported positive clinical trial results showing Tradipitant significantly reduces GLP-1 induced nausea and vomiting.